249 related articles for article (PubMed ID: 31988797)
1. Transcriptomics and Epigenomics in head and neck cancer: available repositories and molecular signatures.
Serafini MS; Lopez-Perez L; Fico G; Licitra L; De Cecco L; Resteghini C
Cancers Head Neck; 2020; 5():2. PubMed ID: 31988797
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma.
Tawk B; Schwager C; Deffaa O; Dyckhoff G; Warta R; Linge A; Krause M; Weichert W; Baumann M; Herold-Mende C; Debus J; Abdollahi A
Radiother Oncol; 2016 Feb; 118(2):350-8. PubMed ID: 26711490
[TBL] [Abstract][Full Text] [Related]
3. Gene Expression Signatures for Head and Neck Cancer Patient Stratification: Are Results Ready for Clinical Application?
Tonella L; Giannoccaro M; Alfieri S; Canevari S; De Cecco L
Curr Treat Options Oncol; 2017 May; 18(5):32. PubMed ID: 28474265
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Radiosensitivity in Head and Neck Squamous Cell Carcinoma Based on Multiple Omics Data.
Liu J; Han M; Yue Z; Dong C; Wen P; Zhao G; Wu L; Xia J; Bin Y
Front Genet; 2020; 11():960. PubMed ID: 33014019
[TBL] [Abstract][Full Text] [Related]
5. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
Foy JP; Bazire L; Ortiz-Cuaran S; Deneuve S; Kielbassa J; Thomas E; Viari A; Puisieux A; Goudot P; Bertolus C; Foray N; Kirova Y; Verrelle P; Saintigny P
BMC Med; 2017 Sep; 15(1):165. PubMed ID: 28859688
[TBL] [Abstract][Full Text] [Related]
6. Molecular Tumor Subtypes of HPV-Positive Head and Neck Cancers: Biological Characteristics and Implications for Clinical Outcomes.
Qin T; Li S; Henry LE; Liu S; Sartor MA
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34072836
[TBL] [Abstract][Full Text] [Related]
7. Molecular prognosticators in clinically and pathologically distinct cohorts of head and neck squamous cell carcinoma-A meta-analysis approach.
Reddy RB; Khora SS; Suresh A
PLoS One; 2019; 14(7):e0218989. PubMed ID: 31310629
[TBL] [Abstract][Full Text] [Related]
8. HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
Linge A; Lohaus F; Löck S; Nowak A; Gudziol V; Valentini C; von Neubeck C; Jütz M; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Buchholz F; Aust DE; Baretton GB; Thames HD; Dubrovska A; Alsner J; Overgaard J; Krause M; Baumann M;
Radiother Oncol; 2016 Dec; 121(3):364-373. PubMed ID: 27913065
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of the expression and prognosis for CDCAs in head and neck squamous cell carcinoma.
Wu ZH; Fang M; Zhou Y
PLoS One; 2020; 15(7):e0236678. PubMed ID: 32716971
[TBL] [Abstract][Full Text] [Related]
10. Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival.
Li H; Torabi SJ; Yarbrough WG; Mehra S; Osborn HA; Judson B
JAMA Otolaryngol Head Neck Surg; 2018 Jun; 144(6):519-525. PubMed ID: 29801040
[TBL] [Abstract][Full Text] [Related]
11. Identification and Validation of an Immune-Related RNA Signature to Predict Survival of Patients With Head and Neck Squamous Cell Carcinoma.
Wu S; Dai X; Xie D
Front Genet; 2019; 10():1252. PubMed ID: 31921296
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a m
Zhao X; Cui L
Am J Cancer Res; 2019; 9(10):2156-2169. PubMed ID: 31720080
[TBL] [Abstract][Full Text] [Related]
13. A three-lncRNA signature derived from the Atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma.
Cao W; Liu JN; Liu Z; Wang X; Han ZG; Ji T; Chen WT; Zou X
Oral Oncol; 2017 Feb; 65():94-101. PubMed ID: 28109476
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor.
De Cecco L; Bossi P; Locati L; Canevari S; Licitra L
Ann Oncol; 2014 Aug; 25(8):1628-35. PubMed ID: 24827125
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
[TBL] [Abstract][Full Text] [Related]
16. Signaling Networks of Activated Oncogenic and Altered Tumor Suppressor Genes in Head and Neck Cancer.
Yan B; Broek RV; Saleh AD; Mehta A; Van Waes C; Chen Z
J Carcinog Mutagen; 2013 Aug; Suppl 7():4. PubMed ID: 25587491
[TBL] [Abstract][Full Text] [Related]
17.
Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
[TBL] [Abstract][Full Text] [Related]
19. Integrative Models of Histopathological Image Features and Omics Data Predict Survival in Head and Neck Squamous Cell Carcinoma.
Zeng H; Chen L; Huang Y; Luo Y; Ma X
Front Cell Dev Biol; 2020; 8():553099. PubMed ID: 33195188
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
